Advertisement

Acta chirurgica Austriaca

, Volume 30, Issue 3, pp 193–194 | Cite as

Invited commentary to: “Atrial natriuretic factor after transjugular intrahepatic portosystemic shunt in liver cirrhosis and ascites”

  • W. O. BechsteinEmail author
  • T. J. Vogl
Originalarbeiten
  • 13 Downloads

Keywords

Aldosterone Liver Cirrhosis Transjugular Intrahepatic Portosystemic Shunt Atrial Natriuretic Factor Alcoholic Cirrhosis 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

References

  1. (1).
    Arroyo V, Gines P: TIPS and refractory ascites. Lessons from the recent history of ascites therapy. J Hepatol 1996;25:221–223.CrossRefPubMedGoogle Scholar
  2. (2).
    Cosenza C, Hoffman AL, Friedman ML, Sher LS, Lopez RR, van Allen R, Brown DH, Fraiman MH, Arnaout W, Vierling J, Makowka L: Transjugular intrahepatic portosystemic shunt: efficacy for the treatment of portal hypertension and impact on liver transplantation. Am Surg 1996;62:835–839.PubMedGoogle Scholar
  3. (3).
    Lebrec D, Giuily N, Handengue A, Vilgrain V, Moreau R, Poynard T, Gadano A, Lassen C, Benhamou J-P, Erlinger S, and a French Group of Clinicians and Group of Biologists: Transjugular intrahepatic portosystemic shunts: Comparison with paracenteses in patients with cirrhosis and refractory ascites: a randomized trial. J Hepatol 1996;25:135–144.CrossRefPubMedGoogle Scholar
  4. (4).
    Martinet J-P, Legault L, Cernacek P, Roy L, Dufresne M-P, Spahr L, Fenyves D, Pomier-Layrargues G: Changes in plasma endothelin-1 and Big endothelin-1 induced by transjugular intrahepatic portosystemic shunts in patients with cirrhosis and refractory ascites. J Hepatol 1996;25:700–706.CrossRefPubMedGoogle Scholar
  5. (5).
    Martinet J-P, Fenyves D, Legault L, Roy L, Dufresne MP, Spahr L, Lafortune M, Pomier-Layrargues G: Treatment of refractory ascites using transjugular intrahepatic portosystemic shunt (TIPS). A caution. Dig Dis Sci 1997;42:161–166.CrossRefPubMedGoogle Scholar
  6. (6).
    Nazarian GK, Bjarnason H, Dietz CA, Bernadas CA, Foshager MC, Ferral H, Hunter DW: Refractory ascites: midterm results of treatment with a transjugular intrahepatic portosystemic shunt. Radiology 1997;205:173–180.CrossRefPubMedGoogle Scholar
  7. (7).
    Neuhaus P, Bechstein WO: Ascites und Lebertransplantation. Chirurg 1993;64:16–20.PubMedGoogle Scholar
  8. (8).
    Pidlich J, Peck-Radosavljevic M, Widling R, Lipinski E, Hartter E, Lenz K, Müller C, Lammer J, Thurnher S, Bieglmayer C, Schneider B, Ferenci P, Gangl A: Atrial natriuretic factor after transjugular inrahepatic postosystemic shunt in liver cirrhosis and ascites. Acta Chir Austriaca 1998;30:189–195.CrossRefGoogle Scholar
  9. (9).
    Runyon BA: Historical aspects of treatment of patients with cirrhosis and ascites. Sem Liver Dis 1997;17:163–173.CrossRefGoogle Scholar
  10. (10).
    Wong F, Sniderman K, Liu P, Blendis L: The mechanism of initial natriuresis after transjugular intrahepatic portosystemic shunt. Gastroenterology 1997;112:899–907.CrossRefPubMedGoogle Scholar

Copyright information

© Blackwell Science Ltd 1998

Authors and Affiliations

  1. 1.Department of General, Visceral and Transplant Surgery, Charité, Campus Virchow-Clinics, Medical FacultyHumboldt UniversitätBerlinGermany
  2. 2.Department of Radiology, Charité, Campus Virchow-ClinicsMedical Faculty of the Humboldt UniversityBerlinGermany

Personalised recommendations